Dexamethasone - POLYPID
Latest Information Update: 14 Jan 2022
At a glance
- Originator POLYPID
- Class Anti-inflammatories; Antiallergics; Antiemetics; Antihyperglycaemics; Antineoplastics; Antirheumatics; Eye disorder therapies; Fluorinated steroids; Glucocorticoids; Ketones; Non-opioid analgesics; Phosphates; Pregnadienetriols; Small molecules; Sodium compounds; Vestibular disorder therapies
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Inflammation
Highest Development Phases
- No development reported Inflammation
Most Recent Events
- 28 Oct 2019 No recent reports of development identified for preclinical development in Inflammation in Israel (Controlled release)
- 21 Apr 2017 Chemical structure information added
- 29 Mar 2017 Dexamethasone - POLYPID is available for licensing as of 29 Mar 2017. http://www.polypid.com